National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings, 28330 [2017-12875]
Download as PDF
asabaliauskas on DSKBBXCHB2PROD with NOTICES
28330
Federal Register / Vol. 82, No. 118 / Wednesday, June 21, 2017 / Notices
the Professionalism and Integrity in
Research Program (PI Program) to
promote research integrity and prevent
research misconduct.
Amount of Award: $135,763 in
Federal Fiscal Year (FFY) 2017 funds
and estimated $135,665 in FFY 2018
funds subject to the enactment of
appropriations and availability of funds.
Project Period: July 1, 2017–June 30,
2019.
ORI performed an objective review of
the unsolicited proposal from
Washington University to expand and
evaluate the Professionalism and
Integrity in Research Program (PI
Program), the only remediation program
for researchers who violate expectations
for the responsible conduct of research.
Based on an external and internal
review of the proposal, ORI determined
that it has merit.
There is a strategic importance of
access to this type of training. Research
misconduct involving Public Health
Service (PHS) support is contrary to the
interests of PHS and the federal
government, the health and safety of the
public, the integrity of research, and the
conservation of public funds.
Participants in the PI Program will
demonstrate better research compliance
and integrity outcomes, such as
developing better, more ethical research
practices. These outcomes will promote
research integrity and help prevent
future research misconduct.
This award is being made noncompetitively because there is no
current, pending, or planned funding
opportunity announcement under
which this proposal could be competed.
ORI has identified three additional key
reasons to support rationale for
awarding this unsolicited proposal:
1. ORI’s federal regulation directs us
to focus on remediation of Respondents
who have been found to commit
research misconduct, and the PI
Program permits a pathway for that
remediation after any sanctions have
been completed.
2. Washington University is uniquely
positioned to provide this type of
training. As the only remediation
program for researchers, the grantee has
developed a comprehensive and
intensive program that will improve
research compliance and integrity
outcomes.
3. With this experience, Washington
University is well known in the research
community and is an important service
to PHS funded institutions. The
program has a robust and unique
process for assessment and data
analysis.
VerDate Sep<11>2014
19:12 Jun 20, 2017
Jkt 241001
Legislative Authority: Sec. 301 of the
Public Health Service Act, 42 U.S.C. 241.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Kathryn M. Partin,
Director of the Office of Research Integrity.
National Institutes of Health
[FR Doc. 2017–12514 Filed 6–20–17; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Partnerships for
Development of Vaccines to Prevent
Mycobacterium Tuberculosis and or
Tuberculosis Disease.
Date: July 18–20, 2017.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Amir E. Zeituni, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 5601 Fishers Lane, MSC–
9834, Rockville, MD 20852, 301–496–2550,
amir.zeituni@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 15, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12873 Filed 6–20–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Clinical
Trial (U01) Review.
Date: July 10, 2017.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health,
Rockville, MD 20850, 301–402–3587, rayk@
nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel.
Date: July 24, 2017.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shiguang Yang, DVM,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD
20892, 301–496–8683, yangshi@
nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: June 15, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–12875 Filed 6–20–17; 8:45 am]
BILLING CODE 4140–01–P
Frm 00037
Fmt 4703
Sfmt 9990
E:\FR\FM\21JNN1.SGM
21JNN1
Agencies
[Federal Register Volume 82, Number 118 (Wednesday, June 21, 2017)]
[Notices]
[Page 28330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12875]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; Clinical Trial (U01)
Review.
Date: July 10, 2017.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Kausik Ray, Ph.D., Scientific Review Officer,
National Institute on Deafness and Other Communication Disorders,
National Institutes of Health, Rockville, MD 20850, 301-402-3587,
rayk@nidcd.nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel.
Date: July 24, 2017.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Shiguang Yang, DVM, Ph.D., Scientific Review
Officer, Division of Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Room 8349, Bethesda, MD 20892, 301-496-8683,
yangshi@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: June 15, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-12875 Filed 6-20-17; 8:45 am]
BILLING CODE 4140-01-P